Women want and need access to a variety of contraceptives to plan, space, and prevent pregnancies. PATH is expanding access and options with DMPA-SC, an all-in-one self-injectable contraceptive …

Nov 19, 2024 · Progestin-only injectable contraceptives (DMPA, 150 mg intramuscularly [DMPA-IM] or 104 mg subcutaneously [DMPA-SC]) are available in the United States; the only difference between …

Description: This educational tool provides a high-level overview of DMPA-SC (the Sayana® Press product). It offers quick facts about DMPA-SC, it’s potential for empowering women and adolescent …

Oct 3, 2025 · DMPA-SC was originally developed and launched by Pfizer over a decade ago under the brand name, Sayana Press. DMPA-SC is a three-month injectable contraceptive that can be …

This resource library has been developed to provide comprehensive information on DMPA-SC evidence, country introduction experiences, service delivery and advocacy tools, and more for global- and …

Nov 13, 2023 · Recently issued WHO guidelines recommend that DMPASC self-injection as part of wider strategies to reduce unmet need, achieve universal access to sexual and reproductive health …

The need for return visits to a healthcare provider may present barriers to access, use, and continuation of DMPA. Studies demonstrate that self-administration of subcutaneous DMPA (DMPA-SC) outside …

Describe the key characteristics, administration, efficacy, and safety profile of DMPA-SC as a contraceptive option. Discuss the benefits and considerations of DMPA-SC self-injection, including …

Self-injected contraception is now an option with the innovative, easy-to-use injectable DMPA-SC. Self-injection with DMPA-SC (brand name Sayana® Press) has the potential to reduce access-related …

DMPA, or DMPA-SC,* is an innovative product that makes injections simpler. Because DMPA-SC is easy to use, any trained person can administer it, including community health workers, pharmacists, …